Here’s what we offer

Custom Pharma Services (CPS) leverages its vast experience of development, manufacturing, quality, regulatory affairs and intellectual property to create valued services for innovator pharmaceutical companies. Integrating various life stages of a new drug, CPS offers development and manufacturing of intermediates, APIs and drug products. In-depth understanding of INDs, clinical phases and NDA filing requirements enable CPS to customise product solutions for its customers, considering flexibility of operation, scale of production, time and cost. CPS is driven by its passion for science and technical challenges.

Know More

Technologies

Our capabilities and experience with complex molecules, help us to understand and solve challenges that pharmaceutical companies face in their quest to get products to the market faster. Our customers have access to the best talents and technologies (including peptides, chirals, HPAPIs, steroids and activated mPEGs) at CPS.

Our capabilities extend to the following technologies:

Know More

Case Studies

Route scouting for an enantiomerically enriched Isoflavone

Designing a non infringing route, obtaining the highest enantiomeric purity, low yields, purification and isolation.

Read More →

Mitigating technical challenges and cost impacts by improved process design

Synthesis of a phase II NCE involved an intermediate with high propensity to racemize and isolated in low yields whereby increasing the cost of the product. In addition, pyrophoric reagents, hydrogenation in specialized reactors, purifications by multiple column chromatography were the major challenges.

Read More →

How the re-designed synthesis of a complex carbohydrate can reduce cycle time

Complex carbohydrate involving a linear sequence of 10 chemical transformations, unstable intermediates and column chromatographic purifications.

Read More →
View all Case Studies
Get In Touch

This website uses cookies to help us give you the best experience when you visit. By using this website you consent to our use of these cookies. For more information on our use of cookies, please review our cookie policy.